GENEXINE, INC.
Patent Owner
Stats
- 12 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Dec 21, 2017 most recent publication
Details
- 12 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 132 Total Citation Count
- Mar 15, 2001 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE46453 Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancerFeb 25, 15Jun 27, 17[A61K, C12N, C07K]
9399665 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancerMar 03, 15Jul 26, 16[A61K, C12N, C07K]
9000139 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancerAug 13, 10Apr 07, 15[C12N, C07K]
8883134 Human interleukin-1 receptor antagonist—hybrid Fc fusion proteinOct 19, 11Nov 11, 14[A61K, C12N, C07K]
8137674 Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancerApr 19, 06Mar 20, 12[A61K]
7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvantAug 02, 07Mar 22, 11[A61K, C07H, A01N, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7989425 Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirusExpiredSep 24, 03Aug 02, 11[A61K, C07H, C12Q, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.